| Product Code: ETC12465219 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The market for immunomodulators in Mauritius saw a shift in concentration levels from high to moderate in 2024, indicating a more diversified import market. Top exporting countries such as India, Metropolitan France, and Germany continue to play a significant role in supplying these products. The CAGR of 4.71% from 2020 to 2024 demonstrates steady growth, although there was a slight decline in the growth rate from 2023 to 2024. This data suggests a stable demand for immunomodulators in Mauritius with potential opportunities for both existing and new exporters in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Immunomodulators Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Immunomodulators Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Immunomodulators Market - Industry Life Cycle |
3.4 Mauritius Immunomodulators Market - Porter's Five Forces |
3.5 Mauritius Immunomodulators Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mauritius Immunomodulators Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Mauritius Immunomodulators Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Mauritius Immunomodulators Market Revenues & Volume Share, By Mode of Action, 2021 & 2031F |
3.9 Mauritius Immunomodulators Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Mauritius Immunomodulators Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Immunomodulators Market Trends |
6 Mauritius Immunomodulators Market, By Types |
6.1 Mauritius Immunomodulators Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Immunomodulators Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Mauritius Immunomodulators Market Revenues & Volume, By Immunosuppressants, 2021 - 2031F |
6.1.4 Mauritius Immunomodulators Market Revenues & Volume, By Immunostimulants, 2021 - 2031F |
6.1.5 Mauritius Immunomodulators Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.6 Mauritius Immunomodulators Market Revenues & Volume, By Peptide-Based Immunomodulators, 2021 - 2031F |
6.1.7 Mauritius Immunomodulators Market Revenues & Volume, By Small Molecule Immunomodulators, 2021 - 2031F |
6.2 Mauritius Immunomodulators Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Immunomodulators Market Revenues & Volume, By Organ Transplantation, 2021 - 2031F |
6.2.3 Mauritius Immunomodulators Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.2.4 Mauritius Immunomodulators Market Revenues & Volume, By Autoimmune Disorders, 2021 - 2031F |
6.2.5 Mauritius Immunomodulators Market Revenues & Volume, By Infectious Disease Treatment, 2021 - 2031F |
6.2.6 Mauritius Immunomodulators Market Revenues & Volume, By Allergy Management, 2021 - 2031F |
6.3 Mauritius Immunomodulators Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Immunomodulators Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Mauritius Immunomodulators Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.4 Mauritius Immunomodulators Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.5 Mauritius Immunomodulators Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.6 Mauritius Immunomodulators Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.4 Mauritius Immunomodulators Market, By Mode of Action |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Immunomodulators Market Revenues & Volume, By T-Cell Suppression, 2021 - 2031F |
6.4.3 Mauritius Immunomodulators Market Revenues & Volume, By Cytokine Activation, 2021 - 2031F |
6.4.4 Mauritius Immunomodulators Market Revenues & Volume, By Antibody Blocking, 2021 - 2031F |
6.4.5 Mauritius Immunomodulators Market Revenues & Volume, By Immune Response Modulation, 2021 - 2031F |
6.4.6 Mauritius Immunomodulators Market Revenues & Volume, By Signal Transduction Blocking, 2021 - 2031F |
6.5 Mauritius Immunomodulators Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Mauritius Immunomodulators Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 Mauritius Immunomodulators Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 Mauritius Immunomodulators Market Revenues & Volume, By Wholesale Suppliers, 2021 - 2031F |
6.5.5 Mauritius Immunomodulators Market Revenues & Volume, By Government Procurement, 2021 - 2031F |
6.5.6 Mauritius Immunomodulators Market Revenues & Volume, By Hospital Contracts, 2021 - 2031F |
7 Mauritius Immunomodulators Market Import-Export Trade Statistics |
7.1 Mauritius Immunomodulators Market Export to Major Countries |
7.2 Mauritius Immunomodulators Market Imports from Major Countries |
8 Mauritius Immunomodulators Market Key Performance Indicators |
9 Mauritius Immunomodulators Market - Opportunity Assessment |
9.1 Mauritius Immunomodulators Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mauritius Immunomodulators Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Mauritius Immunomodulators Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Mauritius Immunomodulators Market Opportunity Assessment, By Mode of Action, 2021 & 2031F |
9.5 Mauritius Immunomodulators Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Mauritius Immunomodulators Market - Competitive Landscape |
10.1 Mauritius Immunomodulators Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Immunomodulators Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here